Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Tandem Diabetes Care Q4 2023 GAAP EPS $(0.46) Misses $(0.27) Estimate, Sales $196.80M Miss $202.76M Estimate

Author: Benzinga Newsdesk | February 21, 2024 05:09pm
Tandem Diabetes Care (NASDAQ:TNDM) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.27) by 70.37 percent. The company reported quarterly sales of $196.80 million which missed the analyst consensus estimate of $202.76 million by 2.94 percent. This is a 10.75 percent decrease over sales of $220.50 million the same period last year.

Posted In: TNDM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist